Identification of lymph node metastases in recurrent colorectal cancer

S. Schneebaum*, A. Troitsa, S. Avital, R. Haddad, H. Kashtan, G. Gitstein, M. Baratz, E. Brazovsky, J. Papo, Y. Skornick

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Lymph node metastases are an important prognostic prediction factor in patients with recurrent colorectal cancer, particularly those with liver metastasis. Fifty-six patients with recurrent colorectal cancer were operated by us using the RIGS (radioimmunoguided surgery) technology. Patients were injected with 1 mg monoclonal antibody (MoAb) CC49 labeled with 2 mCi 125I. In surgery, traditional exploration was followed by survey with a gamma-detecting probe. Sixty of 151 patients enrolled in the Neo2-14 Phase III study for recurrent colorectal cancer were diagnosed with liver metastases based on preoperative CT. In 17/56 patients (30%), RIGS identified at least one tumor site confirmed by pathology (H&E). This resulted in 16 major changes in surgical plan. RIGS performance varied between lymphatic and non-lymphatic tissue, with positive predictive value (PPV) of 100% and negative predictive value (NPV) of 94% for non-lymphoid tissue, compared to PPV of 46.5% and NPV of 100% for the lymphoid tissue. Thirty-five out of 60 patients were considered resectable after traditional evaluation. RIGS identified occult tumor in 10 of these patients (28.5%). 7/10 occult patients expired (70%), while only 7/25 of the non-occult patients expired (28%) (P = 0.046). In localizing patients, no RIGS activity in lymph nodes signifies no tumor, while H&E confirmation is needed for decisions based on RIGS activity in the lymph nodes. RIGS provides important staging information, identifying patients for whom surgery may be done with curative intent.

Original languageEnglish
Pages (from-to)281-292
Number of pages12
JournalRecent Results in Cancer Research
StatePublished - 2000
Externally publishedYes


Dive into the research topics of 'Identification of lymph node metastases in recurrent colorectal cancer'. Together they form a unique fingerprint.

Cite this